EFFICIENCY OF ENDOVASCULAR MYOCARDIAL REVASCULARIZATION AS A «BRIDGE» TO HEART TRANSPLANTATION IN PATIENTS WITH ISCHEMIC HEART FAILURE
https://doi.org/10.15825/1995-1191-2016-4-66-70
Abstract
Aim: to estimate effi ciency of endovascular myocardial revascularization in patients with ischemic chronic heart failure, potential candidates for heart transplantation.
Materials and methods. Survival of 108 patients with ischemic heart disease complicated by chronic heart failure (CHF) after performance of endovascular myocardial revascularization by percutaneous coronary intervention (PCI) is presented. The observation period composed 32.79 ± 6.2 (from 3 to 126) months, age from 33 to 72 (58.9 ± 0.64) years, 102 men, 6 women. Left ventricular (LV) ejection fraction was 34.9 ± 0.6%, EDV 249.75 ± 4.9 ml, ESV 163.27 ± 3.7 ml, mitral regurgitation 1.51 ± 0.07 points. 73% of patients had NYHA Class III CHF, 27% had NYHA Class IV CHF. Duration and quality of life after revascularization were determined. In 2–3 days after PCI dynamics of LV ultrasound parameters were estimated.
Results. At the time of the end of our research 88 from 108 patients (81%) were alive, including 18 patients who underwent heart transplantation (HT). Repeated revascularization was carried out to 19 (17%) patients. 20 patients died: 16 patients with cardiovascular disorders (15%, including 4% of stroke), 3 with pulmonary embolism and 1 with oncological disease. Survival of 90% of the patients composed 4.5 years, 50% survival composed 9 years. At the time of the end of our research the maximum observation period was equal to 126 months. The duration from the fi rst PCI to HT composed from 7.5 to 105 months, mean value – 37 ± 7.5 months. Average life expectancy after HT composed 54.9 ± 24.4 months. Life expectancy from the fi rst PCI composed 87.5 ± 36.9 months. All patients of this group were alive by the time of the end of this research.
Conclusion. Endovascular revascularization in patients with ischemic heart failure in 20% of cases can serve as «bridge» to HT, in 50% of cases it can be considered as an alternative to heart transplantation.
About the Authors
A. B. MironkovRussian Federation
Adress: 26, Bakinskaya st., Moscow, 115516, Russian Federation. Tel. (925) 507-18-42
S. A. Sakhovsky
Russian Federation
Moscow, Russian Federation
I. G. Ryadovoy
Russian Federation
Moscow, Russian Federation
B. L. Mironkov
Russian Federation
Moscow, Russian Federation
References
1. Национальные рекомендации ВНОК И ОССН по диагностике и лечению ХСН (третий пересмотр). Сердечная недостаточность. 2010; 11: 3–62. Nacional’nye rekomendacii VNOK I OSSN po diagnostike i lecheniyu HSN (tretij peresmotr). Serdechnaya nedostatochnost’. 2010; 11: 3–62.
2. Gardner RS. Chronic heart failure: epidemiology, investigation and management / R.S. Gardner, T.A. McDonagh. Medicine. 2014; 42 (10): 562–567.
3. Беленков ЮН. Кардиология. Национальное руководство / Ю.Н. Беленков, Р.Г. Оганов. М.: ГЭОТАР-Медиа, 2008: 1290. Belenkov YuN. Kardiologiya. Nacional’noe rukovodstvo / Yu.N. Belenkov, R.G. Oganov. M.: GEHOTAR-Media, 2008: 1290.
4. Бокерия ЛА, Алекян БГ, Абросимов АВ, Айвазян ГГ. Чрескожные коронарные вмешательства у больных с дисфункцией левого желудочка (фракция выброса меньше или равна 30%). Грудная и сердечно-сосудистая хирургия. 2013; 6: 10–19. Bokeriya LA, Alekyan BG, Abrosimov AV, Ajvazyan GG. Chreskozhnye koronarnye vmeshatel’stva u bol’nyh s disfunkciej levogo zheludochka (frakciya vybrosa men’she ili ravna 30%). Grudnaya i serdechno-sosudistaya hirurgiya. 2013; 6: 10–19.
5. Velazquez EJ, Williams JB, Yow E et al. Long-term survival of patients with ischemic cardiomyopathy treated by coronary artery bypass grafting versus medical therapy. The Annals of Thoracic Surgery. 2012; 93 (2): 23–30.
6. Kunadian V, Pugh A, Zaman AG, Qiu W. Percutaneous coronary intervention among patients with left ventricular systolic dysfunction: a review and meta-analysis of 19 clinical studies. Coron. Artery Dis. 2012 Nov; 23 (7): 469–479.
7. Yancy CW, Jessup M, Bozkurt B et al. 2013 ACCF/AHA guideline for the management of heart failure: executive summary. J. Am. Coll. Cardiol. 2013; 62: 1495–1539.
8. Eric J Velazquez, Kerry L Lee, Robert H Jones, Hussein R Al-Khalidi et al. Coronary- Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy. N. Engl. J. Med. 2016 April 21; 374: 1511–1520. doi: 10.1056/NEJMoa1602001.
9. Болезни сердца по Браунвальду: Руководство по сердечно-сосудистой медицине / П. Либби, Р.О. Боноу, Д.Л. Манн, Д.П. Зайпс. М.: Логосфера, 2013. Т. 3. С. 1753. Bolezni serdca po Braunval’du: Rukovodstvo po serdechno-sosudistoj medicine / P. Libbi, R.O. Bonou, D.L. Mann, D.P. Zajps. M.: Logosfera, 2013. T. 3. S. 1753.
Review
For citations:
Mironkov A.B., Sakhovsky S.A., Ryadovoy I.G., Mironkov B.L. EFFICIENCY OF ENDOVASCULAR MYOCARDIAL REVASCULARIZATION AS A «BRIDGE» TO HEART TRANSPLANTATION IN PATIENTS WITH ISCHEMIC HEART FAILURE. Russian Journal of Transplantology and Artificial Organs. 2016;18(4):66-70. (In Russ.) https://doi.org/10.15825/1995-1191-2016-4-66-70